The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer
Open accessAbstract
More efficient drug delivery system and formulation with less adverse effects are needed for the clinical application of broad-spectrum antineoplastic agent doxorubicin (DOX). Here we obtained outer-membrane vesicles (OMVs), a nano-sized proteoliposomes naturally released by Gram-negative bacteria, from attenuated Klebsiella pneumonia and prepared doxorubicin-loaded O0MVs (DOX-OMV). Confocal microscopy and in vivo distribution study observed that DOX encapsulated in OMVs was efficiently transported into NSCLC A549 cells. DOX-OMV resulted in intensive cytotoxic effects and cell apoptosis in vitro as evident from MTT assay, Western blotting and flow cytometry due to the rapid cellular uptake of DOX. In A549 tumor-bearing BALB/c nude mice, DOX-OMV presented a substantial tumor growth inhibition with favorable tolerability and pharmacokinetic profile, and TUNEL assay and H&E staining displayed extensive apoptotic cells and necrosis in tumor tissues. More importantly, OMVs’ appropriate immunogenicity enabled the recruitment of macrophages in tumor microenvironment which might synergize with their cargo DOX in vivo. Our results suggest that OMVs can not only function as biological nanocarriers for chemotherapeutic agents but also elicit suitable immune responses, thus having a great potential for the tumor chemoimmunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Tacar, O., Sriamornsak, P., & Dass, C. R. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01567.x · Cited by 2,465
Non-small cell lung cancer: current treatment and future advances
Zappa, C., & Mousa, S. A. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.06.07 · Cited by 1,944
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
Schwechheimer, C., & Kuehn, M. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3525 · Cited by 1,922
Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., Wei, J., & Nie, G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.083 · Cited by 1,801
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D. G., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,738
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Immune modulation by bacterial outer membrane vesicles
Kaparakis-Liaskos, M., & Ferrero, R. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3837 · Cited by 1,019
Phagocytosis checkpoints as new targets for cancer immunotherapy
Feng, M., Jiang, W., Kim, B. Y. S., Zhang, C. C., Fu, Y.-X., & Weissman, I. L. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0183-z · Cited by 911
Self-citationBacterial Outer Membrane Vesicles Mediate Cytosolic Localization of LPS and Caspase-11 Activation
Vanaja, S. K., Russo, A. J., Behl, B., Banerjee, I., Yankova, M., Deshmukh, S. D., & Rathinam, V. A. K. (2016) · Cell · doi:10.1016/j.cell.2016.04.015 · Cited by 727
Outer Membrane Vesicles (OMVs) of Gram-negative Bacteria: A Perspective Update
Jan, A. T. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01053 · Cited by 617
Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Park, S.-H., Tan, W., Hong, S. H., Shin, M. G., Chung, I.-J., Hong, Y., Bom, H.-S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aak9537 · Cited by 588
Gujrati, V., Kim, S., Kim, S.-H., Min, J. J., Choy, H. E., Kim, S. C., & Jon, S. (2014) · ACS Nano · doi:10.1021/nn405724x · Cited by 543
Holst, J., Martin, D., Arnold, R., Huergo, C. C., Oster, P., O’Hallahan, J., & Rosenqvist, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.071 · Cited by 405
Corrado, C., Raimondo, S., Chiesi, A., Ciccia, F., De Leo, G., & Alessandro, R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14035338 · Cited by 396
Lin, H.-H., Faunce, D. E., Stacey, M., Terajewicz, A., Nakamura, T., Zhang-Hoover, J., Kerley, M., Mucenski, M. L., Gordon, S., & Stein-Streilein, J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042307 · Cited by 385
Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells
Kesty, N. C., Mason, K. M., Reedy, M., Miller, S. E., & Kuehn, M. J. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600471 · Cited by 375
In vivo toxicity of cationic micelles and liposomes
Knudsen, K. B., Northeved, H., Kumar EK, P., Permin, A., Gjetting, T., Andresen, T. L., Larsen, S., Wegener, K. M., Lykkesfeldt, J., Jantzen, K., et al. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.08.004 · Cited by 356
Methods of isolation and purification of outer membrane vesicles from gram-negative bacteria
Klimentová, J., & Stulík, J. (2015) · Microbiological Research · doi:10.1016/j.micres.2014.09.006 · Cited by 322
Delivery of foreign antigens by engineered outer membrane vesicle vaccines
Chen, D. J., Osterrieder, N., Metzger, S. M., Buckles, E., Doody, A. M., DeLisa, M. P., & Putnam, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805532107 · Cited by 302
Bioengineering bacterial outer membrane vesicles as vaccine platform
Gerritzen, M. J. H., Martens, D. E., Wijffels, R. H., van der Pol, L., & Stork, M. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.05.003 · Cited by 290
Skin Toxic Effects of Polyethylene Glycol–Coated Liposomal Doxorubicin
Lotem, M., Hubert, A., Lyass, O., Goldenhersh, M. A., Ingber, A., Peretz, T., & Gabizon, A. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.12.1475 · Cited by 219
Adriamycin-induced Cardiomyocyte and Endothelial Cell Apoptosis: In Vitro and In Vivo Studies
Wu, S. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2110 · Cited by 197
Gnopo, Y. M. D., Watkins, H. C., Stevenson, T. C., DeLisa, M. P., & Putnam, D. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.003 · Cited by 184
The role of bacterial outer membrane vesicles for intra‐ and interspecies delivery
Berleman, J., & Auer, M. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12048 · Cited by 168
Development of novel nanoantibiotics using an outer membrane vesicle-based drug efflux mechanism
Huang, W., Zhang, Q., Li, W., Yuan, M., Zhou, J., Hua, L., Chen, Y., Ye, C., & Ma, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.11.017 · Cited by 165
The Cancer Immunotherapy Revolution
Kelly, P. N. (2018) · Science · doi:10.1126/science.359.6382.1344 · Cited by 159
F4/80 and the related adhesion‐GPCRs
Gordon, S., Hamann, J., Lin, H., & Stacey, M. A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141715 · Cited by 158
Outer membrane vesicles function as offensive weapons in host–parasite interactions
Amano, A., Takeuchi, H., & Furuta, N. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.05.008 · Cited by 140
Kuipers, K., Daleke, M. H., Jong, W. S. P., ten Hagen‐Jongman, C. M., van Opzeeland, F. J., Simonetti, E. R., Luirink, J., & de Jonge, M. I. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.010 · Cited by 122
Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer
Zhang, X., Fan, J., Wang, S., Li, Y., Wang, Y., Li, S., Luan, J., Wang, Z., Song, P., Chen, Q., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0398 · Cited by 102
Toyofuku, M., Tashiro, Y., Hasegawa, Y., Kurosawa, M., & Nomura, N. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.08.013 · Cited by 101
A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty
Andrews, S. M., & Pollard, A. J. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70341-4 · Cited by 63
Kim, S. W., Kim, J.-S., Papadopoulos, J. N., Choi, H. J., He, J., Maya, M., Langley, R. R., Fan, D., Fidler, I. J., & Kim, S.-J. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.004 · Cited by 52
Cabanes, A., Even‐Chen, S., Zimberoff, J., Barenholz, Y., Kedar, E., & Gabizón, A. (1999) · PubMed · Cited by 52
Cited by
Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications
Mondal, J., Pillarisetti, S., Junnuthula, V., Saha, M., Hwang, S. R., Park, I.-K., & Lee, Y.-K. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.027 · Cited by 416
Wang, J., Liang, S., Chen, S., Ma, T., Chen, M., Niu, C., Leng, Y., & Wang, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02619-w · Cited by 53
Fu, Y., Li, J., Cai, W., Huang, Y., Liu, X., Ma, Z., Tang, Z., Bian, X., Zheng, J., Jiang, J., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.018 · Cited by 48
Metadata
- Authors
- Kuerban, K., Gao, X., Zhang, H., Liu, J., Dong, M., Wu, L., Ye, R., Feng, M., & Ye, L.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 10
- Issue
- 8
- Pages
- 1534-1548
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W3006975085
- Cited by
- 277
- References
- 39
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.